Orthofix Medical Statistics
Orthofix Medical (OM2) Stock Statistics & Valuation Metrics
Total Valuation
Orthofix Medical has a market cap or net worth of EUR 245.60M. The enterprise value is EUR 562.65M.
- Market Cap
- EUR 245.60M
- Enterprise Value
- EUR 562.65M
Share Statistics
Orthofix Medical has 40,759,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 40,759,800
- Owned by Insiders
- 28.28%
- Owned by Institutions
- 46.42%
Financial Efficiency
Orthofix Medical’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -10.01%.
- Return on Equity (ROE)
- -0.20
- Return on Assets (ROA)
- -0.11
- Return on Invested Capital (ROIC)
- -10.01%
- Return on Capital Employed (ROCE)
- -0.10
- Revenue Per Employee
- 512.34K
- Profits Per Employee
- -57.44K
- Employee Count
- 1,605
- Asset Turnover
- 0.97
- Inventory Turnover
- 7.92
Valuation Ratios
The current PE Ratio of Orthofix Medical is -5.93. Orthofix Medical’s PEG ratio is -0.06.
- PE Ratio
- -5.93
- PS Ratio
- 0.32
- PB Ratio
- 0.63
- Price to FCF
- -6.17
- Price to Operating Cash Flow
- 54.33
- PEG Ratio
- -0.06
Income Statement
In the last 12 months, Orthofix Medical had revenue of 822.31M and earned -92.19M in profits. Earnings per share was -2.28.
- Revenue
- 822.31M
- Gross Profit
- 551.71M
- Operating Income
- -68.47M
- Pretax Income
- -90.81M
- Net Income
- -92.19M
- EBITDA
- 9.93M
- Earnings Per Share (EPS)
- -2.28
Cash Flow
In the last 12 months, operating cash flow was 5.01M and capital expenditures -48.68M, giving a free cash flow of -43.67M billion.
- Operating Cash Flow
- 5.01M
- Free Cash Flow
- -43.67M
- Free Cash Flow per Share
- -1.06
Dividends & Yields
Orthofix Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -16.21%
- Earnings Yield
- -16.53%
Stock Price Statistics
- Beta
- 0.35
- 52-Week Price Change
- -53.17%
- 50-Day Moving Average
- 7.78
- 200-Day Moving Average
- 9.06
- Relative Strength Index (RSI)
- 31.71
- Average Volume (3m)
- 25
Important Dates
Orthofix Medical upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Feb 19, 2027
- Ex-Dividend Date
- ―
Financial Position
Orthofix Medical as a current ratio of 2.45, with Debt / Equity ratio of 50.94%
- Current Ratio
- 2.45
- Quick Ratio
- 2.24
- Debt to Market Cap
- 0.31
- Net Debt to EBITDA
- 14.82
- Interest Coverage Ratio
- -3.92
Taxes
In the past 12 months, Orthofix Medical has paid 1.38M in taxes.
- Income Tax
- 1.38M
- Effective Tax Rate
- -0.02
Enterprise Valuation
Orthofix Medical EV to EBITDA ratio is 4.38, with an EV/FCF ratio of -9.57.
- EV to Sales
- 0.50
- EV to EBITDA
- 4.38
- EV to Free Cash Flow
- -9.57
- EV to Operating Cash Flow
- 83.42
Balance Sheet
Orthofix Medical has EUR 86.32M in cash and marketable securities with EUR 234.85M in debt, giving a net cash position of -EUR 148.53M billion.
- Cash & Marketable Securities
- EUR 86.32M
- Total Debt
- EUR 234.85M
- Net Cash
- -EUR 148.53M
- Net Cash Per Share
- -EUR 3.64
- Tangible Book Value Per Share
- EUR 4.17
Margins
Gross margin is 69.17%, with operating margin of -0.65%, and net profit margin of -5.39%.
- Gross Margin
- 69.17%
- Operating Margin
- -0.65%
- Pretax Margin
- -5.18%
- Net Profit Margin
- -5.39%
- EBITDA Margin
- 11.41%
- EBIT Margin
- -2.36%
Analyst Forecast
The average price target for Orthofix Medical is EUR 9.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 9.10
- Price Target Upside
- 54.16% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- -2.99%
- EPS Growth Forecast
- 66.06%
Scores
- Smart Score
- 5
- AI Score
- ―

